255 related articles for article (PubMed ID: 17845961)
1. ACR Appropriateness Criteria on staging and follow-up of ovarian cancer.
Javitt MC
J Am Coll Radiol; 2007 Sep; 4(9):586-9. PubMed ID: 17845961
[TBL] [Abstract][Full Text] [Related]
2. Staging and follow-up of ovarian cancer. American College of Radiology. ACR Appropriateness Criteria.
Fishman EK; Mendelson E; Böhm-Vélez M; Bree R; Finberg H; Hricak H; Laing F; Sartoris D; Thurmond A; Goldstein S; Walsh J
Radiology; 2000 Jun; 215 Suppl():899-902. PubMed ID: 11037515
[No Abstract] [Full Text] [Related]
3. ACR appropriateness criteria staging and follow-up of ovarian cancer.
Mitchell DG; Javitt MC; Glanc P; Bennett GL; Brown DL; Dubinsky T; Harisinghani MG; Harris RD; Horowitz NS; Pandharipande PV; Pannu HK; Podrasky AE; Royal HD; Shipp TD; Siegel CL; Simpson L; Wong-You-Cheong JJ; Zelop CM;
J Am Coll Radiol; 2013 Nov; 10(11):822-7. PubMed ID: 24183551
[TBL] [Abstract][Full Text] [Related]
4. CA-125 and early ovarian cancer: does this help the clinician or further muddy the water?
McGuire WP
J Clin Oncol; 2005 Sep; 23(25):5862-4. PubMed ID: 16087955
[No Abstract] [Full Text] [Related]
5. Surgical management of women with ovarian cancer.
Cooper A; DePriest P
Semin Oncol; 2007 Jun; 34(3):226-33. PubMed ID: 17560984
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7.
Lambeck AJ; Crijns AP; Leffers N; Sluiter WJ; ten Hoor KA; Braid M; van der Zee AG; Daemen T; Nijman HW; Kast WM
Clin Cancer Res; 2007 Apr; 13(8):2385-91. PubMed ID: 17438097
[TBL] [Abstract][Full Text] [Related]
7. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
[TBL] [Abstract][Full Text] [Related]
8. [Imaging procedures in diagnosis of ovarian carcinoma].
Häusler G; Schurz B
Wien Med Wochenschr; 1996; 146(1-2):8-10. PubMed ID: 8835488
[TBL] [Abstract][Full Text] [Related]
9. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI.
Kim HS; Kim JW; Cho JY; Chung HH; Park NH; Song YS; Kim SH; Kang SB
Eur J Surg Oncol; 2009 Aug; 35(8):870-6. PubMed ID: 19179039
[TBL] [Abstract][Full Text] [Related]
10. [Ovarian carcinoma--diagnosis and treatment. Consensus conference of the National Institute of Health].
Bornkessel B
Med Monatsschr Pharm; 1995 Oct; 18(10):292-6. PubMed ID: 7476655
[No Abstract] [Full Text] [Related]
11. Diagnosis and treatment of epithelial ovarian cancer.
Schwartz PE
Minerva Ginecol; 2003 Aug; 55(4):315-26. PubMed ID: 14581856
[TBL] [Abstract][Full Text] [Related]
12. An atypical presentation of ovarian cancer.
Moustafa M; Beynon WB
J Obstet Gynaecol; 2002 Jul; 22(4):455-6. PubMed ID: 12521490
[No Abstract] [Full Text] [Related]
13. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
14. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
15. Importance of early diagnosis in managing ovarian cancer.
Dunleavey R
Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
[TBL] [Abstract][Full Text] [Related]
16. Recognition and initial management of ovarian cancer: summary of NICE guidance.
Redman C; Duffy S; Bromham N; Francis K;
BMJ; 2011 Apr; 342():d2073. PubMed ID: 21511784
[No Abstract] [Full Text] [Related]
17. Ovarian Cancer Management: the role of imaging and diagnostic challenges.
Bharwani N; Reznek RH; Rockall AG
Eur J Radiol; 2011 Apr; 78(1):41-51. PubMed ID: 21392907
[TBL] [Abstract][Full Text] [Related]
18. An unusual presentation of Stage III ovarian carcinoma.
Noor S; Khan R; Hollingworth A
J Obstet Gynaecol; 2005 Aug; 25(6):619-20. PubMed ID: 16234164
[No Abstract] [Full Text] [Related]
19. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
